IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
2027 Edition
Banking and finance
29 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
Capital markets : Debt
18 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
Capital markets : Equity
14 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
Capital markets : Structured finance and securitisation
9 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
Financial services regulatory
21 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
M&A
40 firms ranked
View full list

Tier 1 ...


Unlock this content.

These rankings will be officially released on October 14. Subscribers can view the rankings now through exclusive early access.

Request Early Access Login to continue
12 results12 results
Deal Highlights
37 results37 results
Deal Name Deal Date Firm Name Jurisdiction Deal Type Lawyer Names Client Names Client Role
Nova Reperta - M&A
2021-07-22
Baker McKenzie
Belgium
M&A
Luc Meeus
Nova Reperta
Seller
De Cuyper family - M&A
2021-11-25
Baker McKenzie
Belgium
M&A
Arne Naert, Koen Vanhaerents, Pieter-Jan Denys, Quinten Saey
De Cuyper family
Seller
Cadence Design Systems Inc. - M&A
2021-01-20
Baker McKenzie
Belgium
M&A
Alison Stafford Powell, Amanda Bradley, Barry Chang, Brian Stanton, Celine Somers, Denise Glagau, Eline Kegels, Jenna Kalashyan, Joseph Deng, Julie Van thienen, Kai Kramer, Koen Vanhaerents, Leif King, Marcela Robledo, Margo Allaerts, Michael De Vroey, Patrick Renckly, Philippe Lion, Pieter-Jan Denys, Sebastian Burg
Cadence Design Systems Inc.
Buyer
Aurelius Equity Opportunities SE & Co. KGaA - M&A
2022-08-30
Baker McKenzie
Belgium
M&A
Aurelius Equity Opportunities SE & Co. KGaA
Buyer
Bank Degroof Petercam; Belfius Bank - Secondary share offering
2022-07-03
Baker McKenzie
Belgium
Secondary share offering
Roel Meers
Bank Degroof Petercam, Belfius Bank
Underwriter
Berenberg Bank; KBC Securities; Belfius Bank; Oppenheimer Europe - M&A
2021-05-07
Baker McKenzie
Belgium
M&A
Roel Meers, Adam Farlow
Berenberg Bank, KBC Securities, Belfius Bank, Oppenheimer Europe
Seller
Fortino Capital Partners - Fund formation
2021-01-06
Baker McKenzie
Belgium
Fund formation
Luc Meeus
Fortino Capital Partners
Investor
HOWEST; Cronos Groep; BNP Paribas Fortis - Fund formation
2021-10-13
Baker McKenzie
Belgium
Fund formation
Luc Meeus
HOWEST, Cronos Groep, BNP Paribas Fortis
Investor
MDxHealth - IPO
2021-08-11
Baker McKenzie
Belgium
IPO
Roel Meers, Megan Schellinger
MDxHealth
Issuer
Mithra Pharmaceuticals - Secondary share offering
2022-07-02
Baker McKenzie
Belgium
Secondary share offering
Roel Meers
Mithra Pharmaceuticals
Issuer
Newton Biocapital Partners - Fund formation
2021-12-23
Baker McKenzie
Belgium
Fund formation
Luc Meeus
Newton Biocapital Partners
Investor
Noshaq - Fund formation
2021-01-10
Baker McKenzie
Belgium
Fund formation
Luc Meeus
Noshaq
Investor
Orange Belgium - M&A
2021-06-05
Baker McKenzie
Belgium
M&A
Koen Vanhaerents
Orange Belgium
Target
Sequana Medical - Secondary share offering
2022-02-15
Baker McKenzie
Belgium
Secondary share offering
Roel Meers
Sequana Medical
Issuer
SRIW; Sogepa - Fund formation
2021-12-22
Baker McKenzie
Belgium
Fund formation
Luc Meeus
SRIW, Sogepa
Investor
Aquinos - M&A
2022-02-24
Baker McKenzie
Belgium
M&A
Dominique Maes
Aquinos
Acquirer
Vivalto Vie Holding SAS  - M&A
2022-01-31
Baker McKenzie
Belgium
M&A
Luc Meeus
Vivalto Vie Holding SAS 
Acquirer
C-Lab International - M&A
2021-01-03
Baker McKenzie
Belgium
M&A
Dominique Maes
C-Lab International
Acquirer
OpenGate Capital Management, LLC  - M&A
2021-02-03
Baker McKenzie
Belgium
M&A
Dominique Maes
OpenGate Capital Management, LLC 
Acquirer
Paccor Packaging GmbH  - M&A
2021-01-06
Baker McKenzie
Belgium
M&A
Christian Atzler
Paccor Packaging GmbH 
Acquirer
1
of
2
Targeted partner hires in antitrust, funds and finance show how firms are strengthening priority benches while elite rivals supply senior talent
M&A
We round up new hires across the M&A, PE, corporate and finance practices at leading law firms in the UK, Ireland, and US
New hires were made across the corporate, finance and M&A practices in the US, UK and Europe
Partners at Hogan Lovells Hong Kong, Allen & Gledhill Singapore, and Baker McKenzie Japan share insights on the 2026 outlook for private credit market in the APAC region
New hires and promotions were made across finance, PE and M&A practices in London, Singapore, New York and Santiago
M&A
New hires and promotions were made across the PE, corporate, M&A, finance and capital markets practices in Frankfurt, Munich, London, New York and São Paulo
M&A
After more than 26 years at the firm, M&A partner Dominique Maes talks purpose, people and the art of closing deals
New hires were made across the financial regulation, M&A and investment funds practices in London, New York and Chicago
Sponsored

Sponsored

IFLR Sponsored

should have bg #f6f8fb but is leaving an artifact

IFLR1000 Sponsored